> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-134/
- Published: 2017-05-21T12:00:00.000Z
- Updated: 2026-09-14T22:24:49.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138689

[**FDA Amends Animal Drug Regs to Reflect Approvals**](https://www.fdaweb.com/fda-amends-animal-drug-regs-to-reflect-approvals/) 05/17/2017  
*Federal Register* final rule: FDA amends the animal drug regulations to reflect application-related actions for new animal drug applications and abbreviated new animal drug applications during January and February.

[**FDA Withdrawing Approval of Sioux Bio Animal Drug**](https://www.fdaweb.com/fda-withdrawing-approval-of-sioux-bio-animal-drug/) 05/18/2017  
*Federal Register* notice: FDA withdraws approval of a new animal drug application at the sponsors’ request because the product is no longer manufactured or marketed.

[**Comments Sought on Revisions to FDA Blueprint for Opioid Prescribers**](https://www.fdaweb.com/comments-sought-on-revisions-to-fda-blueprint-for-opioid-prescribers/) 05/18/2017  
*Federal Register* notice: FDA announces the availability of draft revisions to the “FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics.”